The effect of COVID-19 pandemic restrictions on neovascular AMD patients treated with treat-and-extend protocol.
Mehmet Orkun SevikAslan AykutGamze ÖzkanVolkan DericioğluÖzlem ŞahinPublished in: International ophthalmology (2021)
More than half of the scheduled nAMD patients in TAE protocol missed their IVI visits during the RP, which resulted in a delay of their treatments. The delay of IVI treatment in those patients resulted in an increase in OCT disease activity and a decrease in BCVA.
Keyphrases
- end stage renal disease
- disease activity
- newly diagnosed
- randomized controlled trial
- chronic kidney disease
- rheumatoid arthritis
- systemic lupus erythematosus
- prognostic factors
- peritoneal dialysis
- rheumatoid arthritis patients
- ankylosing spondylitis
- age related macular degeneration
- optical coherence tomography
- patient reported
- combination therapy
- replacement therapy
- optic nerve